IXC
Click for more information
0.00% 6.5¢ invex therapeutics ltd

Ann: Invex Granted Type C Meeting with FDA, page-50

  1. TheDerivative
    343 Posts.
    lightbulb Created with Sketch. 23
    clock Created with Sketch.
    13/05/21
    22:41
    Post #: 53164309
    expecting much more share price pain short term then Ark?
    watching this share price slide to where it is, you’re comments around the market preferring FDA to EMA seem to be fairly accurate.

    IXC Price at posting: 66.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
6.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $4.885M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 24 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
7.7¢ 7950 1
View Market Depth
Last trade - 16.12pm 03/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.